Red X iconGreen tick iconYellow tick icon
Skip to main content Skip to side navigation
  • Jensen BP, Chin PKL, Begg EJ. Quantification of total and free concentrations of R- and S-warfarin in human plasma by ultrafiltration and LC-MS/MS. Anal Bioanal Chem 2011; 401(7), 2187–93 [Abstract]
  • Vella-Brincat J, McKean A, Barclay M. Clozapine-induced gastrointestinal hypomotility (Letter). Aust Psychol 2011; 19(5), 450-1 [Abstract]
  • Bentley RW, Keown D, Merriman TR, Krishnan MR, Gearry RB, Barclay ML, et al. Vitamin D receptor gene polymorphism associated with inflammatory bowel disease in New Zealand males (Letter). Aliment Pharmacol Ther 2011; 33, 855-6 [Abstract]
  • Stamp LK, O'Donnell JL, Zhang M, James J, Frampton C, Barclay ML, Chapman PT. Using allopurinol above the dose based on creatinine clearance is effective and safe in chronic gout, including in those with renal impairment. Arthritis Rheumatol 2011; 63(2), 412-21 [Abstract]
  • Larsen HS, Chin PKL, Begg EJ, Jensen BP. Quantification of total and unbound concentrations of lorazepam, oxazepam and temazepam in human plasma by ultrafiltration and LC-MS/MS. Bioanalysis 2011; 3(8), 8433-552 [Abstract]
  • Polasek TM, Lin FPY, Miners JO, Doogue MP. Perpetrators of pharmacokinetic drug-drug interactions arising from altered cytochrome P450 activity: a criteria-based assessment. Br J Clin Pharmacol 2011; 71(5), 727-36 [Abstract]
  • Chin PKL, Jensen BP, Larsen HS, Begg EJ. Adult age and ex vivo protein binding of lorazepam, oxazepam and temazepam in healthy subjects. Br J Clin Pharmacol 2011; 72(6), 985–9 [Abstract]
  • Lin FPY, Anthony S, Polasek TM, Tsafnat G, Doogue MP. BICEPP: an example-based statistical text mining method for predicting the binary characteristics of drugs. BMC Bioinformatics 2011; 12(1), 112 [Abstract]
  • Doogue MP, Polasek TM. Drug dosing in renal disease. Clin Biochem Rev 2011; 32(2), 36 [Abstract]
  • Graham GG, Punt J, Arora M, Doogue MP, et al. Clinical pharmacokinetics of metformin. Clin Pharmacokinet 2011; 50(2), 81-98 [Abstract]
  • Panchaud A, Garcia-Bournissen F, Csajka C, Kristensen JH, Taddio A, Begg EJ. Prediction of infant drug exposure through breastfeeding: population PK modeling and simulation of fluoxetine exposure. Clin Pharmacol Ther 2011; 89(6), 830–6 [Abstract]
  • Stamp LK, Barclay ML, O'Donnell JL, Zhang M, Drake J, Frampton C, Chapman PT. Relationship between serum urate and plasma oxypurinol in the management of gout: determination of minimum plasma oxypurinol concentration to achieve a target serum urea level. Clin Pharmacol Ther 2011; 90(3), 392-8 [Abstract]
  • Morgan AR, Han DY, Lam WJ, Triggs C, Fraser AG, Barclay M, et al. Genetic variations in matrix metalloproteinases may be associated with increased risk of ulcerative colitis. Hum Immunol 2011; 72, 1117-27 [Abstract]
  • Roberts RL, Hollis-Moffatt JE, Gomez-Garcia M, Fransen K, Barclay ML, et al. Association of the protein-tyrosine phosphatase nonreceptor type substrate 1 (PTPNS!) gene with inflammatory bowel disease (Letter). Inflamm Bowel Dis 2011; 17(2), E19-21 [Abstract]
  • Diaz-Gallo LM, Espino-Paisan L, Fransen K, Gomez-Garcia M, Barclay ML, et al. Differential association of two PTPN22 coding variants with Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2011; 17(11), 2287-94 [Abstract]
  • Jensen BP, Vella-Brincat JWA, Begg EJ. Quantification of cyclizine and norcyclizine in human plasma by liquid chromatography-tandem mass spectrometry (LC-MS/MS). J Chromatogr B 2011; 879(9), 605-9 [Abstract]
  • Zhang M, Moore GA, Jensen BP, Begg EJ, Bird PA. Determination of dexamethasone and dexamethasone sodium phosphate in human plasma and cochlear perilymph by liquid chromatography/tandem mass spectrometry. J Chromatogr B 2011; 879(1), 17-24 [Abstract]
  • Gardiner SJ, Gearry RB, Burt MJ, Chalmers-Watson T, Barclay ML, et al. Allopurinol might improve response to azathioprine and 6-mercaptpurine by correcting an unfavourable metabolite ratio. J Gastroenterol Hepatol 2011; 26, 49-54 [Abstract]
  • Fairhall M, Reid K, Vella-Brincat J, Walker J, Chin P, Jensen B, Macleod S, Begg E. Exploring hospice patients' views about participating in research (Letter). J Pain Symptom Manage 2011; 4(22) [No abstract]
  • Stamp LK, Barclay ML, O'Donnell JL, Zhang M, Drake J, Frampton C, Chapman PT. Effects of changing from oral to subcutaneous methotrexate on red blood cell methotrexate polyglutamate concentrations and disease activity in patients with rheumatoid arthritis. J Rheumatol 2011; 38(12), 2540-7 [Abstract]
  • Valentine NA, Alhawasso TM, Roberts GW, Vora PP, Doogue MP, et al. Detecting undiagnosed diabetes using glycated haemoglobin: an automated screening test in hospitalised patients. Med J Aust 2011; 194(4), 160-4 [Abstract]
  • Vella-Brincat JWA, Begg EJ, Robertshaw BJ, Lynn AM, Borrie TL, Darlow BA. Are gentamicin and/or vancomycin associated with ototoxicity in the neonate? A retrospective audit. Neonatology 2011;100(2), 186-93 [Abstract]
  • Anderson CA, Boucher G, Lees CW, Franke A, Barclay M, et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 (Letter). Nat Genet 2011; 43, 246-52 [Abstract]
  • Kershaw V, Vella-Brincat J, McKean A. A better night's sleep: an audit of medications used to treat insomnia in a psychiatric inpatient unit. NZ Med J 2011; 124(1339/40), [Abstract]
  • Vella-Brincat JWA, McKean A. Ten-year dispensing trends of hypnotics in New Zealand. NZ Med J 2011; 124(1330/1), [Abstract]
  • Rossin EJ, Lage K, Raychaudhuri S, Xavier RJ, Tatar D, et al. Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology. PLoS Genet 2011; 7(1), 1-13 [Abstract]
  • Polasek TM, Doogue MP, Miners JO. Metabolic activation of Clopidogrel: in vitro data provide conflicting evidence for the contributions of CYP2C19 and PON1. Ther Adv Drug Saf 2011; 2(6), 253-61 [Abstract]
  • Glubb D, Gearry RB, Barclay ML, Roberts RL, Pearson J. NOD2 and ATG16L1 polymorphisms affect monocyte responses in Crohn's disease. World J Gastroenterol 2011; 17(23), 2829-37 [Abstract]
  • Bird PA, Murray DP, Zhang M, Begg EJ. Intratympanic versus intravenous delivery of dexamethasone and dexamethasone sodium phosphate to cochlear perilymph. Otol Neurotol 2011; 32(6), 933-6 [Abstract]
  • Stamp LK, Chapman PT, Barclay M, Kremer JM, Dervieux T. Red blood cell folate polyglutamates are an important determinant of RA disease activity in patients on methotrexate-implications for folic acid supplementation. Arthritis Rheumatol 2011; 63(10), S961-2 [Abstract]
Back to top